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Attaching/Effacing(A/E) pathogens include Enteropathogenic Escherichia 
coli (EPEC) and Enterohemorrhagic E. coli (EHEC), which cause 
gastroenteritis and are significant causes of foodborne diseases worldwide. 
Citrobacter rodentium (CR), as the murine equivalent, produces the same 
characteristic A/E lesions. While CR causes self-limiting infection in 
immunocompetent hosts, the morbidity and mortality are significantly 
higher in immunocompromised hosts. In the infection cycle of CR, the 
pathogen senses the changes of external environment and expresses an 
array of virulence factors. However, the adaptation process and critical 
host-pathogen interactions under immunocompromised conditions remain 
elusive.  We utilized the infection of wild-type CR in interleukin-22 (Il-22) 
knockout (Il22-/-) mice as a model to dissect the crucial host-pathogen 
interactions during CR infection in immunocompromised hosts associated 
with severe symptoms and mortality. Previous studies from our lab utilizing 
RNA-sequencing (RNA-seq) analysis of gene transcription in host-adapted 
CR derived from the infected Il22-/- mice and in vitro culture reveal a 




them, several genes were significantly upregulated in host-adapted CR, 
indicating that they might function as important virulence factors 
accounting for the infection-caused severe symptoms and lethality, 
including bioF, fepA, and Rod_48101. Here, we generated chromosomal 
knockout strains of bioF, fepA, and Rod_48101 and assessed the impacts of 
deletions of these genes on CR proliferation in vitro and virulence in vivo. 
Our results demonstrate that deletion of these genes does not impair the 
proliferation of CR in vitro. Meanwhile, infections with ΔfepA, ΔbioF, and 
ΔRod-48101 strains still result in severe body weight loss and high mortality 
in the infected Il22-/- mice, as does by wild-type CR. Therefore, our findings 
suggest that bioF, fepA, and Rod_48101 is dispensable for CR virulence in 
the immunocompromised Il22-/- mice. The dramatic upregulation of these 
genes is most likely the consequences of, rather than the causative triggers 
for the severe inflammatory responses resulting in mortality during CR 
infection in Il22-/- mice. Our results also indicate a complex host-pathogen 
interactions and bacterial virulence regulatory mechanisms during A/E 
pathogen infections in immunocompromised hosts associated with severe 
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Attaching/Effacing (A/E) pathogens; Citrobacter rodentium infection 
Diarrheagenic pathogens are the second cause of infection related death 
among children under the age of 5 years (WHO, 2017), and pathogenic 
Escherichia coli is a major contributor1–3. While around six pathotypes of 
pathogenic E. coli have been associated with enteric diseases, 
Enteropathogenic Escherichia coli (EPEC) and Enterohemorrhagic 
Escherichia coli (EHEC) share distinctive virulent mechanisms. Both EHEC 
and EPEC form characteristic histological lesions on intestinal mucosa, 
characterized by attachment to the host intestinal epithelial cells (IECs) and 
effacement of the brush border microvilli 2,4,5. Formation of A/E lesions 
requires a unique protein secretion system termed type III secretion system 
(T3SS), which is mainly encoded in locus of enterocyte effacement (LEE) 
pathogenicity island6,7. The structure of LEE and the function of T3SS 
effectors have been well described8. EHEC/EPEC have around 5000 genes in 
the genome, but only a small portion of non-T3SS related genes have been 





Naturally, EPEC and EHEC do not infect mice, which brings difficulties in 
establishing mouse model. This could be the result of competence with 
other intestinal commensals, since pretreatment with antibiotics enables 
the colonization of EHEC/EPEC in mice intestinal lumen9. The mouse 
pathogen Citrobacter rodentium (CR), which causes transmissible colonic 
crypt hyperplasia, is the only natural murine A/E pathogen10. CR shares 67% 
of its genes with EHEC/EPEC, including critical virulence factors like LEE 
island10, type IV pilus11, and a type VI secretion system10. CR infection forms 
nearly identical A/E lesions from those caused by EHEC/EPEC in human12–14, 
which makes it an ideal model for researching the virulence factors as well 
as host-pathogen interaction mechanisms of A/E pathogens. Most studies 
apply an oral inoculation method of laboratory-cultured CR, which robustly 
results in intestinal infection15,16. In 1-3 days post inoculation (DPI), a small 
portion of CR firstly colonize at the caecal lymphoid patch while the 
majority just pass through the gastrointestinal tract17,18. From 4 DPI, CR 
starts to adhere to the IECs of distal colon and rectum, where it expresses 
virulence genes, proliferates, and reach the peak of bacterial load12,18,19. 
From 12 DPI, CR load starts to decrease as colonized IECs are shed into the 




bacteria clearance by opsonizing and phagocytosis21,22. During the infection 
cycle, CR triggers an excessive cell proliferation and repair response: 
pericryptal myofibroblasts secrete R-spondin 2 (RSPO2), which activates the 
WNT pathway of LGR5+ stem cell23. LGR5+ stem cells are the progenitor of 
IECs, and overactivation of LGR5+ stem cells results in accumulation of 
undifferentiated transit amplifying cells, which causes crypt elongation and 
thickening of intestinal mucosa24,25. Moreover, these poorly differentiated 
colonocytes have decreased expression of carbonic anhydrase 4 and HCO3- - 
Cl- exchanger SLc26a3, which results in disruption of ion exchange and fluid 
loss26. Usually, for immunocompetent C57BL/6 mice, infection of CR leads 
to mild and self-limited symptoms including diarrhea, hematochezia, and 
body weight loss27. In 2-3 weeks post infection, CR will be completely 
cleared, and mice develop protection against reinfection eventually28,29.  
Since CR is shed into the intestinal lumen and feces during mid-late stage of 
infection, it could also be transmitted to other mice in the same litter via 
coprophagy. Strikingly, after passing through the gastrointestinal tract, CR 
shows significantly higher infectivity, as it establishes infection with 1000-
fold lower CFU19,30. Moreover, in the fecal-oral route infection, such 




directly colonize at the distal colon29. These outcomes suggest an adaption 
process in the caecum, in which bacteria sense the change of external 
environment and express virulence factors, including T3SS4. While the 
detailed mechanism beneath this adaption is largely unknown, various 
studies suggest that CR receives multiple signals including variation of 
temperature31, host-derived chemicals32–34, microbiota metabolites35,36 and 
mechanical forces 37. These signals triggers expression of a series of genes, 
including LEE, which plays a critical role in the initial infection stage. 
However, it remains elusive whether other genes are involved in the host-
adaption process and the mechanism of the regulation of virulence factors 
is largely unknown. 
 
Role of Il-22 in host immune response to C. rodentium infection 
To achieve sterile clearance of CR, both innate and adaptive immune 
response are required. Briefly, CR infection is first detected by pattern 
recognition receptors (PRRs) including TLR2, TLR4, TLR9, NOD1, and 
NOD238–41. These PRRs trigger downstream response including pro-




and recruitment of neutrophils, macrophages and dendritic cells 42–47. 
Collectively, these responses restrict the dissemination of the pathogen, 
and provide critical signals for effector lymphocytes. In the clearance phase, 
B cell as well as CD4+ T cells are indispensable. T cell activated plasma cells 
secret IgG, which opsonizes CR for activation of complement system and 
promotes phagocytosis by neutrophils21,22,48,49. Meanwhile, the rest luminal 
CR is outcompeted by commensals29, which leads to complete clearance of 
CR in around 21 days post infection. 
Various cytokines are involved in the innate and adaptive immune response 
against CR infection, including IL-6, IL-12, IFNγ, IL-1β, IL-18, IL-17, IL-23, and 
IL-2241,50–54. Notably, IL-22 is believed to play a critical role in host immune 
response to CR infection, which is supported by the significantly elevated 
mortality (nearly 100%) of CR infected Il-22-/- mice27. During the infection, 
the major source of IL-22 shifts from type 3 innate lymphoid cells (ILC3s) in 
the expansion phase55 to neutrophils in the steady-state phase 56,57and 
Th17 and Th22 cells in the clearance phase58,59. IL-22 has 2 important 
functions against CR infection. First, IL-22 directly stimulates IECs cells to 
secret antimicrobial peptides (AMPs) including S100A family protein, 




RegIIIβ directly inhibit CR by chelating essential nutritional metal ions and 
biding to lipidA, respectively62–66. While no evidence suggests that RegIIIγ 
protein directly kills CR, studies indicate that RegIIIγ protein has protective 
effects in CR infection, probably by protecting mice from complicating 
Gram-positive bacterial infection27,67. Meanwhile, IL-22 promotes intestinal 
integrity by upregulating tight junction protein claudin-168 and promoting 
fucosylation of mucins, which reduces the risk of dissemination and 
systematic infection67. Moreover, some studies indicate that IL-22 is 
involved in regulation of intestinal microbiota, which could be another 
mechanism of its anti-CR effect67,69. Various studies indicate that patients 
with autoimmune diseases or chronic HIV infection have lower IL-22 level70–
72, which may renders them more vulnerable to A/E pathogen related 
infection. However, the virulence regulation mechanism of CR infection in 








Several genes were upregulated in host-adapted C. rodentium. 
To identify novel regulation factors of CR, we performed RNA-seq on both 
host-adapted and wild type CR strains. The sequencing data was mapped to 
CR genome and normalized into RPKM (Reads Per Kilobase Million) values 
(Fig 1). Compared to wild type CR, host-adapted CR showed significantly 
higher expression of several genes, including fepA, bioF, and an 
unannotated gene Rod_48101, hinting that these genes could be potential 





                               
Figure 1 Upregulation of potential virulence factors in host-adapted C. rodentium. 
RNA-seq experiment on host-adapted (n=8) and laboratory-cultured (n=4) CR was 
performed previously. The raw data of RNA-seq was mapped to the CR genome and 
normalized into RPKM values.  Two-tailed Student’s t test was conducted for statistical 
analysis. (ns, not significant, * p < 0.05, ** p < 0.01, and **** p < 0.001) 
Generation of gene-knockout C. rodentium strains. 
In this study, scarless chromosomal deletion method was utilized to 
construct mutated CR strains. Primers were designed to amplify the 




or to test the presence of junction fragments (Fig 2.1 & Table 2). 
 
Figure 2 Diagram for primer design in scarless gene knockout 3 sets of primers were 
used in the scarless gene knockout experiment. The Up 1100/1000-Dw 900/800 primer 
pairs were used to amplify the homologous arms of target genes and create overlap 
regions with pRE112. The Up-Dw primer pairs were used to detect the junction region of 
homologous arms on the recombined vector or mutated genome. The Up-Gene primer 
pairs were used to detect the presence of target gene on the genome. 
PCR-synthesized homologous arms and linearized pRE112 plasmid were 
conjugated via Gibson Assembly. These vectors were transformed into 




were picked and PCR confirmed to ensure the presence of fusion sequences 
on pRE112(Fig 3).  
 
Figure 3 Synthesis of homologous arms and PCR confirmation of Gibson Assembly. (A) 
The homologous arms of fepA (1100/900bp), bioF (1100/900 bp), and Rod_48101 
(1000/800bp) were synthesized via PCR and were analyzed in 1% agar gel. (B) After 
electroporation, colonies with chloramphenicol resistance were cultured in LB broth and 
the recombined plasmids were extracted, PCR confirmed, and analyzed in 1% agar gel. 




 The vectors were further transferred into wild type CR, and after two 
rounds of allelic recombination, colonies with only Amp resistance (from 
helper plasmid pKD46) were cultured and PCR checked to select the target 
gene knockout strains (Fig 4). All constructs were further verified that no 
additional mutations were introduced via Sanger sequencing. 
 
Figure 4 PCR confirmation of gene knockout. Colonies with only ampicillin resistance 
were cultured and confirmed via PCR, and WT CR was used as a negative control. Two 
primer pairs were used in the PCR: Up-Dw pair to detect the fusion fragment of up-
down sequences, and Up-Gene pair to detect the presence of target gene. Samples with 
expected PCR product using Up-Dw pair and no product using Up-Gene pair were 
regarded as positive results. 
Deletion of fepA, bioF, and Rod_48101 does not impair the proliferation 




As previous studies showed that Il-22-/- mice were extremely vulnerable to 
wild type CR infection and showed nearly 100% of mortality, we 
hypothesized that infection by these mutated CR stains would result in 
decreased severity and mortality, if the correlated genes were involved in 
pathogenesis. To rule out the possibility that deletion of candidate genes 
impaired the proliferation of CR, we first measured the growth curve of the 
three candidates along with WT CR in LB broth. Moreover, Dulbecco’s 
Modified Eagle Medium (DMEM) is proved to strongly induce the 
expression of T3SS of CR6,7,29, which could better mimic the “activated” 
state of CR. Therefore, growth curve was measured in DMEM as well. In 
both conditions, all three gene knockout strains showed no growth defect 




Rod_48101 are not directly involved in proliferation, thus the mutant 
strains are suitable for the following in vivo infection experiment.  
 
Figure 5 Growth curves of wild type, ΔbioF, ΔfepA, and ΔRod_48101 C. rodentium 
strains in LB broth (A)and DMEM(B). Growth curves of indicated CR strains in LB 
medium (A) and Dulbecco’s Modified Eagle’s Medium(B), at 1:50 dilution from 
normalized overnight culture. 




fepA, bioF, and Rod_48101 are dispensable for C. rodentium induced 
lethal infection on Il-22-/- mice. 
We carried in vivo infection experiments to assess the pathogenetic 
capacity of ΔbioF, ΔfepA, ΔRod_48101, and WT CR strains on Il-22-/- mice. 
Clinical manifestations, body weight change, and fecal CR CFU were 
monitored after inoculation. All four groups of mice manifested typical CR 
infection symptoms: diarrhea, dehydration, hematochezia, and significant 
weight loss (Fig 6). There were no significant differences in relative body 
weight loss between WT CR and three CR mutants at all time spots (Fig 7). 
 
Figure 6 Body weight loss of wild type, ΔbioF, ΔfepA, and ΔRod_48101 C. rodentium 
infected mice. Weight loss of Il-22-/- mice at indicated time post inoculation with wild 





Figure 7 Relative body weight loss of Wild Type, ΔbioF, ΔfepA, and ΔRod_48101 C. 
rodentium infected mice. Relative body weight loss of Il-22-/- mice at indicated time 
post inoculation with wild type, ΔbioF, ΔfepA, or ΔRod_48101 CR.  
 
Consistently, WT CR infection showed 100% lethality by 14 DPI and the 
median survival time was 7 days. The median survival time of ΔbioF and 
ΔfepA group showed no significant difference with WT group, whereas 




median survival time (Fig 8). 
 
Figure 8 Survival curve of wild type, ΔbioF, ΔfepA, and ΔRod_48101 C. rodentium 
infected mice. Log-rank analysis of the survival rate in Il-22-/- mice inoculated with wild 
type, ΔbioF, ΔfepA, or ΔRod_48101 CR. ns, not significant; * p<0.05. 
 
Correspondingly, ΔRod_48101 CR infected mice showed 100-1000 fold 
lower fecal CR CFUs compared with WT or ΔbioF/ΔfepA CR infected groups 






Figure 9 Fecal C. rodentium Load of wild type, ΔbioF, ΔfepA, and ΔRod_48101 C. 
rodentium infected mice. Fecal samples were obtained at indicated time post 
inoculation with wild type, ΔbioF, ΔfepA, and ΔRod_48101 CR. Samples were serial 
diluted in sterile PBS and plated on MacConkey plates. The CFU values of each sample 
were normalized to the mass of the feces. 
 To further ascertain this result, we carried a repetitive in vivo infection 
experiment of ΔRod_48101 CR strain. WT CR served as a negative control 
and A12F6 mutated CR strain served as a positive control, which showed no 
mortality in previous experiments. Infection with ΔRod_48101 CR still 
caused severe weight loss as WT CR did. The median survival time and 
mortality at 14 DPI of WT and ΔRod_48101 CR group showed no difference. 
On the contrary, infection with A12F6 CR only led minor body weight 
fluctuation and no mortality was observed even in 15 DPI (Fig 10&11&12). 




dispensable for CR induced mortality on Il-22-/- mice. However, these genes 
might still be involved in CR host-pathogen interaction and regulation of 
virulence (see Discussion).  
 
Figure 10 Body weight loss of wild type, A12F6, and ΔRod_48101 C. rodentium infected 
mice (Repetitive experiment). Weight loss of Il-22-/- mice at indicated time post 
inoculation with wild type, A12F6, or ΔRod_48101 CR. 
 
Figure 11 Relative Body weight loss of wild type, A12F6, and ΔRod_48101 C. rodentium 
infected mice (Repetitive experiment). Relative weight loss of Il-22-/- mice at indicated 





Figure 12 Survival curve of wild type, A12F6, and ΔRod_48101 C. rodentium infected 
mice (Repetitive experiment). Log-rank analysis of the survival rate in Il-22-/- mice 












While Citrobacter rodentium infection creates a good animal model to 
investigate the pathogenesis of A/E pathogens EHEC and EPEC, the host-
pathogen interactions in immunocompromised/immunodeficient hosts 
remains largely unknown. Moreover, a recent study indicates that the 
circulating IL-22 levels in infants are lower thus they are more susceptible 
to severe infection73, which just further increases the urgency. Here we 
demonstrate that bioF, fepA, and Rod_48101, while are significantly 
upregulated in the pathogenesis of CR, are not essential virulence factors of 
CR. Deletion of these genes could neither impair the proliferation and 
colonization of CR nor alleviate the body weight loss or reduce the 
mortality in infected Il-22-/- hosts. Although we did observe a significant 
change in the survival curve of ΔRod_48101 CR infected mice in the first 
round of infection, we believe that this significance could simply be 
attributed to the unusual survival of the last mouse in this group. Several 
studies suggest that, except for the virulence capacity of CR, genetic 
background and composition of intestinal microbiota also influence the 




differences23,74,75. The survival curves and body weight change curves of 
this research also suggest that some individuals are more 
resistant/vulnerable to CR infection. Therefore, a large sample size should 
be applied in the future to diminish the bias introduced by individual 
differences. 
 
It remains unknown why these genes were significantly upregulated in 
host-adapted CR. Since the absence of these genes did not impair the 
virulence capacity of CR, we hypothesize that they are involved in 
redundant pathways that could be compensated by systems with similar 
function. bioF encodes a highly conserved 8-amino-7-oxononanoate 
synthase, which catalyzes the first step of biotin biosynthesis76. Biotin acts 
as an essential cofactor for carboxylases and decarboxylase. While human 
could only acquire biotin from external source, microorganisms are able to 
either synthesize biotin de novo or absorb it from the environment77. This 
bi-phase system is strictly regulated by biotin protein ligase BirA, which acts 
as a biotin metabolism mediator as well as a negative regulator of biotin 
synthetic operon. When the supplement of biotin exceeds the demand, 




transcription of the operon, which contains bioF78–80. This sensing and 
regulation mechanism plays an important role in CR pathogenesis. Humans 
absorb biotin majorly in the small intestine. This absorption is highly 
effective, which results in a lower environmental biotin concentration in 
the small intestine than in the colon81. Since we obtained host-adapted CR 
in the distal colon, it is reasonable that host-adapted CR has a higher 
expression level of bioF than those obtained from a biotin-rich 
environment. Moreover, Bin Yang reported that BirA is negatively 
associated with T3SS via fur (ferric uptake regulation protein) in EHEC. This 
mechanism ensures that A/E pathogens express T3SS and attach to the 
epithelial cells in the large intestine, which is more hostile35. The outer 
membrane protein fepA, which serves as the receptor of siderophore ferric 
enterobactin, is a key component of bacterial iron uptake system82. Since 
the cellular concentration of free ferric ions is usually too low for bacteria 
to survive, bacteria evolved different mechanisms to obtain iron from 
different iron-binding protein. Enterobactin is a high affinity iron chelator 
secreted by CR to overcome the limitation of iron supply. Enterobactin 
could from a high stable coordinate compound with iron, which enables 




FeEnt, is recognized by membrane protein FepA and transported into the 
bacteria84,85. This mechanism may explain the upregulation of fepA in host-
adapted CR. Meanwhile, in the host immune response to CR, IL-22 induces 
secretion of multiple bactericidal proteins, including lipocalin-2, which 
could sequester iron from siderophores (bacterial iron chelating agents, like 
enterobactin)63,86. This mechanism, together with the fact that CR has 
additional iron transporting mechanisms other than fepA-enterobactin, 
may explain our findings that fepA knockout CR strains could still 
proliferate and cause death in IL-22 deficiency mice82,87. Finally, although 
Rod_48101 has not been annotated so far, homology analysis suggests that 
it is a putative siderophore-interacting protein88. Therefore, the 
upregulation of Rod_48101 could be attributed to the activation of iron 
uptake system. 
 
Taken together, our data shows that bioF, fepA, and Rod_48101, while are 
significantly upregulated in host-adapted CR, are not indispensable 
virulence factors in the pathogenesis of CR on Il-22-/- mice. Our findings 
indicate a complex host-pathogen interactions and bacterial virulence 




















Material and Methods 
Ethics statement 
All animal experiments were performed according to protocol number 
MO19H269, approved by the Johns Hopkins University’s Animal Care and 
Use Committee. Il-22 knockout (Il-22-/-) mice in C57Bl/6 background were 
maintained in a specific pathogen-free facility and fed autoclaved food and 
water ad libitum. 
 
Cell culture, reagents, and plasmids 
Wild type, ΔbioF, ΔfepA, and ΔRod_48101 C. rodentium strains were grown 
in LB broth at 37℃ overnight with shaking. Chloramphenicol (Cm, 25mg/L) 
and ampicillin (Amp, 100mg/L) LB agar plates were used to select positive 
strains. Salt free LB agar plates with 5% sucrose were used to selected 
colonies that underwent secondary recombinant. Suicidal plasmid pRE112 
was used as the vector, which contains a chloramphenicol resistance gene 
CmR as a selective marker, a SacB gene for secondary recombination and 
SacI/KpnI cleavage sites. Restrictive endonucleases SacI and KpnI were used 





Constructing gene-knockout CR strains 
ΔbioF, ΔfepA, and ΔRod_48101 CR strains were generated using a scarless 
gene deletion method via SacB-based allelic exchange. A suicidal vector, 
pRE112, was linearized by digestion of restriction endonuclease SacI and 
KpnI. Homologous arms of target genes were generated by high-fidelity PCR 
from WT CR genomic DNA using LiSparkTM SuFi PCR Master Mix (LifeSct, 
Rockville, MD) and were assembled with the linearized vector using Gibson 
Assembly Master Mix (New England BioLabs, Ipswich, MA). The recombined 
vector was transformed into SY327 using a Bio-Rad MicroPulser (Bio-Rad 
Laboratories, Hercules, CA) and positive colonies were selected using Cm 
containing LB agar plates. The colonies were PCR confirmed using 2xLiTaqTM 
PCR Master Mix (LifeSct, Rockville, MD). The recombined pRE112 was 
extracted and transformed into SM10 via heat shock, which later 
conjugated with CR and passed the vector. The colonies were cultured and 
plated on Cm LB agar plates, where they underwent the first allelic 
exchange to incorporate the vector. Cm-resistant CR colonies were cultured 




the secondary allelic exchange to expel the SacB gene. Colonies with only 
Amp resistance were PCR confirmed for the Up-Down conjugation part, and 
desired strains were Sanger sequenced to get rid of additional mutations. 
 
Growth curve measurement  
Wild type, ΔbioF, ΔfepA, and ΔRod_48101 C. rodentium strains were grown 
in LB broth at 37℃ overnight with shaking. The medium was normalized to 
OD600=1 and was diluted at 1:50 and grown at 37℃ with shaking. 1ml of C. 
rodentium culture was taken at indicated time to read OD600 value in a 96-
well plate with a CO8000 Cell Density Meter (Biochrom, UK). 
 
CR infection in mice 
Male Il-22 knockout mice (12-18 weeks) were fasted for 6 hours before 
inoculation. Wild type, ΔbioF, ΔfepA, and ΔRod_48101 C. rodentium strains 
were grown in LB broth at 37℃ overnight with shaking. The medium was 
normalized to OD600=1, and then concentrated by 10 times in PBS. Each 




rodentium strains. Mice were observed once in two days for weight loss 
and mortality.  
 
Bacterial counts 
Stool samples were collected at indicated times post inoculation. Samples 
were homogenized and diluted in PBS (100μl PBS for 10mg stool). The 
supernatant was serial diluted and plated on MacConkey plates, incubated 
overnight at 37℃. C. rodentium CFUs were calculated the following day. 
 
Statistical analysis 
All statistical analysis was performed with GraphPad Prism version 8.0.2 
(GraphPad Software, San Diego, CA). Mean with standard errors of means 
(S.E.M.) or median with range were plotted in graphs and were detailed in 
figure legends. Statistical analysis on survival curves was performed using 
the log-rank (Mantel-Cox) test. Statistical analysis on gene expression levels 
and relative body weight change was performed using Student’s t test. 
Significant differences were considered: ns, non-significant difference; * at 
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RESEARCH EXPERIENCES          
The virulence regulation of bacterial pathogen Citrobacter rodentium 
in immunocompromised mice (01/2020-Present) 
Advisor: Prof. Fengyi Wan, Dept. of Biochemistry & Molecular Biology, 
JHSPH 
⚫ Constructed plasmids for scarless gene knockout in C. rodentium. 
⚫ Generated 7 gene knockout C. rodentium strains.  
⚫ Assess the impacts of candidate gene deletions on CR infection 
caused mortality and clinical manifestation in interleukin 22 
knockout (Il22-/-) mice. 
⚫ Constructing a library of Tn5-inserted C. rodentium mutants and 
screening for novel zinc transporter genes.  
Oncogenic FAP Positive Fibroblasts Promote Intrahepatic 
Cholangiocarcinoma (ICC) via MDSC Recruitment (09/2018-07/2019) 
Advisor: Prof. Rui He, Dept. of Immunology, School of Basic Medical 




⚫ Illustrated that FAP positive cancer associated fibroblasts (CAFs) play 
a critical role in promoting tumor growth of ICC via myeloid-derived 
suppressor cells (MDSCs) using siRNA-mediated gene knock-down and 
cell co-culturing system. 
⚫ Identified ALOX5 as the key gene upregulated in CAFs-activated 
MDSCs and MDSCs-derived LTB4 as a key mediator in maintaining 
tumor stemness in ICC microenvironment via NGS analysis, WB, ELISA 
and cell co-culture. 
⚫ Identified BLT2 as the major surface receptor of LTB4 on ICC cells and 
mTOR activation following LTB4-BLT2 interaction via NGS analysis, 
specific antagonist blocking and WB. 
⚫ Hypothesized IL6 and IL33 as potential pro-tumor cytokines secreted 
by FAP positive CAFs stimulated MDSCs via NGS analysis and GSEA. 
(Validated by subsequent work)  
⚫ Participated in identifying CCL2 as a key promoter secreted by FAP 
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Advisor: Prof. Naishuo Zhu, Dept. of Microbiology, School of Life Science, 
Fudan U 
⚫ Fundamental training for molecular biology, immunology, and animal 
experiments. 
⚫ Separated TILs from tumor-bearing mice via MACS. Preliminary 
research on its anti-neoplastic capacity after PD-L1 antibody 
treatment. 
Summer Research Program: Training for Bioinformatics in Stem Cell 
Research (06/2018-08/2018) 
Advisor: Dr. Bing Zhang, Harvard University. (Present: Prof. in Westlake 
University) 
⚫ Transcriptome analysis (RNA-seq data) of skin stem cells with 





Summer Research Program: Research and Modification on 
Magnetotactic Bacteria (08/2018-09/2018) 
Advisor: Prof. Wei Lin, Institute of Geology and Geophysics, Chinese 
Academy of Science 
⚫ Cultured magnetotactic bacteria from natural environment with self-
created device. Modified magnetosome of MB with cobalt and 
research on its chemical and magnetic property. 
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